Arc-1 Review: Price, Pros & Cons
Arc-1 is a compounded GLP-1 telehealth seller founded by board-certified physician Dr. Todd Stearns, pricing semaglutide and tirzepatide by dose from $199.99 a month, with a free consultation and free shipping.
In this review
Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.
Prices at a glance
- Semaglutide
- $199.99/mo0.5 mg starting dose, compounded; $249.99 at 1 mg, $549.99 at 2.5 mg
- Tirzepatide
- $199.99/mo2.5 mg starting dose, compounded; $249.99 at 5 mg, $399.99 at 7.5 mg
- Coverage
- Coverage not published
- Brand-name
- Not confirmed
Semaglutide · estimated annual cost
$2,400
Tirzepatide · estimated annual cost
$2,400
Who Arc-1 may suit
Shoppers starting on a low dose who are comfortable with a price that rises as the dose goes up.
Where the value is
- Each dose has its own price in the cart, so you can see what moving up will cost
- Free consultation and free shipping, with no separate visit fee
- Named founder physician (Dr. Todd Stearns)
- LegitScript certified, with a wider longevity catalog (NAD+, rapamycin, B12)
The tradeoffs
- Prices rise steeply with the dose: semaglutide goes from $199.99 to $549.99 a month
- The tirzepatide product page says 'starting at $149/month', but the lowest dose in the cart is $199.99
- No compounding pharmacy is named and no state list is published
- You pay at checkout before the medical intake
Arc-1's prices go up with the dose
Arc-1 sells compounded semaglutide and tirzepatide, and each dose has its own monthly price:
| Semaglutide dose | Price | Tirzepatide dose | Price |
|---|---|---|---|
| 0.5 mg | $199.99/mo | 2.5 mg | $199.99/mo |
| 1 mg | $249.99/mo | 5 mg | $249.99/mo |
| 2.5 mg | $549.99/mo | 7.5 mg | $399.99/mo |
So the starting price is the same for both drugs, but the cost climbs as your provider moves you up. A year on the higher semaglutide dose costs more than twice as much as the starting dose. Plan for that before you begin.
One mismatch to know about: the tirzepatide product page says "starting at $149/month," while the lowest tirzepatide dose in the cart is $199.99. Go by the cart, and ask support if you see the lower figure at checkout.
Considering Arc-1?
Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.
How ordering works
Arc-1 runs like an online store. You add the medication to your cart and complete checkout first. The consultation fee is $0. After you pay, you get a secure intake form, and licensed practitioners review your information and decide whether the prescription is right for you. If you're approved, it ships free and discreetly.
Arc-1 was founded by Dr. Todd Stearns, a board-certified physician, and you can book a 20-minute consultation with him. Semaglutide is given as a weekly injection. Arc-1 says its medication is prepared by licensed compounding pharmacies but doesn't name them.
Things to check before you buy
- Arc-1 doesn't publish the states it serves. Make sure yours is covered before you pay, since payment comes before the intake.
- Ask what happens to your payment if a practitioner doesn't approve you.
- Its refund policy doesn't spell out terms, so ask support how canceling and refunds work.
- Compounded semaglutide and tirzepatide aren't FDA-approved, whatever a product description suggests.
The Index scorecard
Arc-1 scored on our six Cost-Efficiency Index factors. See the methodology.
The bottom line
Arc-1 is a compounded GLP-1 telehealth seller founded by board-certified physician Dr. Todd Stearns, pricing semaglutide and tirzepatide by dose from $199.99 a month, with a free consultation and free shipping.
Compare the total cost of other GLP-1 programs and alternatives to Arc-1 before deciding. A clinician should help you choose the right treatment.
Other programs to compare with Arc-1
These are partners: we may earn a commission if you sign up, at no cost to you.
MEDGmPartner
Semaglutide modeled $299/mo · Tirzepatide modeled $399/mo
MEDGm charges $299 a month for compounded semaglutide injections and $399 for tirzepatide once the $120 welcome coupon lapses, prints every plan length on its product pages, and names the four pharmacies that fill its prescriptions.
Luvo HealthPartner
Semaglutide modeled $226.42/mo · Tirzepatide modeled $269.75/mo
Luvo charges $209 every four weeks for compounded semaglutide and $249 for tirzepatide, with half off the first delivery and brand-name Ozempic or Zepbound available.
MyDrHankPartner
Semaglutide modeled $249/mo · Tirzepatide modeled $349/mo
Every price this site advertises is a twelve-month prepay rate — its price display returns the cheapest term by design — so the real month-to-month cost is $249-$349, not the "from $171" on the page.
Compare with other providers
The providers whose Cost-Efficiency Index scores sit closest to Arc-1's. See the alternatives to Arc-1.
- Framework— Framework offers doctor-guided compounded GLP-1 plans with nutrition support, while the medication price appears after intake.57/100
- myRocky— MyRocky lists branded GLP-1 products, oral Rybelsus and a separate $397 compounded semaglutide offer. The program adds a $99 monthly care fee, and the medication pack prices need a confirmed supply length.57/100
- Magnolia Regenerative Medicine— Magnolia Regenerative Medicine was a clinic selling compounded GLP-1s alongside hormone and recovery programs; its website no longer exists.57/100
- 24hrDOC— 24hrDOC is a cash-pay telehealth service for common conditions that also advertises compounded semaglutide, $299 for the injection and $309 for the oral form, with a 6-month subscription recommended.56/100
- Boston Medical Group— Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss program.56/100
- HelloWellness— HelloWellness sells compounded GLP-1 plans paid up front and renewed every 11 weeks, so its advertised three-month equivalents understate the ongoing calendar-month average.56/100
Pricing, states and verification reflect Arc-1's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Arc-1's site. Not medical advice; see our disclosure.